Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05386173

Effect of Fetal Aortic Valvuloplasty on Outcomes

Effect of Fetal Aortic Valvuloplasty on Outcomes. A Prospective Observational Cohort Study With a Comparison Cohort

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Queen Silvia Children's Hospital, Gothenburg, Sweden · Academic / Other
Sex
All
Age
23 Weeks – 31 Weeks
Healthy volunteers
Not accepted

Summary

In one of the most severe congenital heart defects, hypoplastic left heart syndrome (HLHS), the left ventricle is underdeveloped and the prognosis is worse than in most other heart defects. The underdevelopment can occur gradually during fetal growth caused by a narrowing of the aortic valve. At some international centers, such fetuses are treated with a balloon dilation of the narrowed valve, but there is no scientifically sound evidence that this treatment is effective. The aim of this study is: 1/ to evaluate whether balloon dilation during the fetal period of a narrowed aortic valve can reduce the risk of the left ventricle becoming underdeveloped and the baby being born with a so-called univentricular heart (HLHS); 2/ to investigate whether such treatment improves the prognosis for this group of children with a very complex and severe heart defect and 3/ to also describe side effects and risks in fetuses and mothers of the fetal procedure.

Detailed description

Routinely collected pre- and postnatal clinical data will be entered into a digital database and echocardiographic examinations will be uploaded to a server. A core lab will measure and analyze all echocardiographic examinations according to protocol. The growth of the left heart structures and the postnatal outcome will be compared between the intervention and non-intervention groups. The decision whether a fetal balloon dilatation shall be attempted is not part of the study protocol. The number of examinations of mother/fetus/infant in this study is not different from the number of examinations that will be recommended for someone choosing not to be part of this study. Participation in the study does not affect the care and treatment mothers and fetuses are receiving during pregnancy, nor how the infant is examined and treated after birth.

Conditions

Interventions

TypeNameDescription
PROCEDUREFetal aortic balloon dilatationFetal valvuloplasty will be performed as described in Arzt W, Wertaschnigg D, Veit I, Klement F, Gitter R, Tulzer G. Intrauterine aortic valvuloplasty in fetuses with critical aortic stenosis: experience and results of 24 procedures. Ultrasound Obstet Gynecol. 2011;37:689-695. with minor variations between centers involved. Technical success is defined as improved forward flow and/or new aortic regurgitation.

Timeline

Start date
2021-01-01
Primary completion
2029-12-31
Completion
2029-12-31
First posted
2022-05-23
Last updated
2025-03-21

Locations

13 sites across 8 countries: United States, Austria, Canada, Finland, Germany, Poland, Spain, Sweden

Source: ClinicalTrials.gov record NCT05386173. Inclusion in this directory is not an endorsement.